Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
EPA Decision Not To Ban Asbestos Blasted In New England Journal of Medicine Editorial July 16, 2019 Irvin Jackson Add Your Comments A recent decision by U.S. regulators to allow continued and new uses of asbestos is being slammed in an editorial published last week in a prominent medical journal, questioning the decision in the face of years of evidence that asbestos exposure can cause slow and painful deaths. The editorial was published in the New England Journal of Medicine on July 10, castigating the U.S. Environmental Protection Agency (EPA) and the Trump Administration as a whole for failing to enact an asbestos ban, despite clear and present dangers to public health. Dr. Philip J. Landrigan and Dr. Richard A. Lemen are the authors of the editorial, and both are former senior officials of the National Institute for Occupational Safety and Health. Lemen was its deputy director and is a retired assistant surgeon general. Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The editorial notes that every year nearly 40,000 Americans die from asbestos diseases, such as mesothelioma, asbestosis, lung cancer, ovarian cancer and laryngeal cancer. Most of these deaths are painful and protracted, and treatment of the various conditions cost the country hundreds of millions of dollars annually, according to the editorial. The authors indicate that the risks of asbestos exposure have been known for about a century, although they did not get widely publicized until 1964. Most modern, first-world countries have banned asbestos use in its entirety decades ago. But not the United States. While most uses were banned in this country, there is still about 750 metric tons of asbestos used in the U.S. every year. The EPA was given a chance to ban asbestos again in 2016, as part of a new chemical safety law meant to require safety reviews of key chemicals. Asbestos was identified as one of the first 10 chemicals to be reviewed. However, the Trump Administration halted the review, and it has been stalled ever since, despite provisions in the law which make the reviews a requirement. The EPA again refused to put an outright ban on asbestos in place in April 2019, as part of a significant new use rule. That decision came amid public comments by doctors, health experts and consumers that supported a ban. In May, The New York Times published internal memos showing even the EPA’s own experts were against the decision. Instead, the agency allowed manufacturers to seek approval for new uses of asbestos, as well as some older uses, despite known health risks associated with the toxic substance. EPA personnel objected to claims that “new uses” of asbestos could be safer, of narrow definitions of what asbestos is, and also complained that the EPA was only considering lung cancer and mesothelioma as potential asbestos harms. “We believe that this administration’s brazen attempt to continue and potentially expand asbestos use in the United States is an affront to public health and human dignity,” the editorial states. “It signals acceptance of the asbestos industry’s long-disproven claims that chrysotile asbestos, the only form of asbestos on international markets today, is safe and that it is possible to work safely with asbestos. It ignores more than five decades of medical research that has established beyond any reasonable doubt that even in very small amounts, all forms of asbestos, including chrysotile, can cause cancer.” The writers threw their support behind a bill put forward in March by New Jersey Congressman Frank Pallone, Jr.: the Alan Reinstein Ban Asbestos Now Act of 2019. It would ban not only production, but also use and importation of asbestos in the United States. Exposure to asbestos has been linked to a number of serious and life-threatening health risks, including mesothelioma, lung cancer, asbestosis and other ailments. Mesothelioma is a particularly deadly cancer, which is only known to result from breathing asbestos fibers. As a result of a long latency period of between 20 and 40 years between exposure to asbestos and diagnosis, the cancer is often at a very advanced stage by the time it is discovered and usually results in death. Currently, asbestos is banned for use in corrugated paper, roll board, commercial paper, and specialty paper, flooring felt and new commercial uses that begin after August 25, 1989. However, even though the fibrous material is toxic even in small amounts, it is still in use in some industries. It is frequently used in automobile brake pads and clutches, vinyl tiles and roofing materials. Tags: Asbestos, Asbestos Exposure, Asbestosis, EPA, Lung Cancer, Mesothelioma Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Mesothelioma Lawsuit Stories EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024 EPA Bans Last Uses of Toxic Asbestos in the United States March 19, 2024 U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025) Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025) Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)
EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024
U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024
Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)
Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)
Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)